Mechanism of Action: Retatrutide acts on three receptors (triple agonist): GLP-1 (appetite suppression), GIP (fat metabolism), and glucagon (energy expenditure), providing a more potent metabolic effect than dual or single agonists.
Benefits: Trials have demonstrated profound weight loss (nearly 29% body weight reduction in 68 weeks)
, improved glycemic control, reduced blood pressure, improved cholesterol, and reduced knee osteoarthritis pain.